These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9594373)

  • 1. Long-term effect of low-density lipoprotein apheresis in a patient with heterozygous familial hypercholesterolemia: follow-up study using coronary angiography.
    Saku K; Takeda Y; Jimi S; Okabe M; Shirai K; Nii T; Naito S; Arakawa K
    J Cardiol; 1998 Apr; 31(4):239-45. PubMed ID: 9594373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).
    Aengevaeren WR; Kroon AA; Stalenhoef AF; Uijen GJ; van der Werf T
    J Am Coll Cardiol; 1996 Dec; 28(7):1696-704. PubMed ID: 8962554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
    Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
    Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
    Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery bypass grafting in familial hypercholesterolemia.
    Kawasuji M; Sakakibara N; Takemura H; Matsumoto Y; Mabuchi H; Watanabe Y
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):364-9. PubMed ID: 7853888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of heterozygous familial hypercholesterolemia showing the regression of coronary atherosclerosis by LDL-apheresis].
    Nomura S; Kouzuma R; Komura T; Sadayasu T; Segawa J; Nakashima Y; Kuroiwa A
    Kokyu To Junkan; 1992 Mar; 40(3):299-302. PubMed ID: 1579754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO; Donner MG; Höfling B; Schwandt P
    Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS).
    Nishimura S; Sekiguchi M; Kano T; Ishiwata S; Nagasaki F; Nishide T; Okimoto T; Kutsumi Y; Kuwabara Y; Takatsu F; Nishikawa H; Daida H; Yamaguchi H
    Atherosclerosis; 1999 Jun; 144(2):409-17. PubMed ID: 10407502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia.
    Koga N
    Ther Apher; 2001 Aug; 5(4):244-51. PubMed ID: 11724508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of familial hypercholesterolemia; secession from LDL-apheresis by the drug treatment with potent statin and resin.
    Shiina Y; Homma Y; Oguma T; Fusegawa Y; Ozawa H; Handa S; Tanabe T
    Tokai J Exp Clin Med; 2005 Sep; 30(3):149-55. PubMed ID: 16285605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term probucol treatment results in regression of xanthomas, but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia.
    Kajinami K; Nishitsuji M; Takeda Y; Shimizu M; Koizumi J; Mabuchi H
    Atherosclerosis; 1996 Feb; 120(1-2):181-7. PubMed ID: 8645359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on coronary atherosclerosis of long-term treatment of familial hypercholesterolemia by LDL-apheresis.
    Mabuchi H; Koizumi J; Michishita I; Takeda M; Kajinami K; Fujita H; Inazu A; Uno Y; Shimizu M; Takeda R
    Beitr Infusionsther; 1988; 23():87-96. PubMed ID: 2484787
    [No Abstract]   [Full Text] [Related]  

  • 13. Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy.
    Masaki N; Tatami R; Kumamoto T; Izawa A; Shimada Y; Takamatsu T; Katsushika S; Ishise S; Maruyama Y; Yoshimoto N
    Int Heart J; 2005 Sep; 46(5):833-43. PubMed ID: 16272774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.
    Tsuchida M; Kawashiri MA; Tada H; Takata M; Nohara A; Ino H; Inazu A; Kobayashi J; Koizumi J; Mabuchi H; Yamagishi M
    Circ J; 2009 May; 73(5):963-6. PubMed ID: 19088396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
    Vishwanath R; Hemphill LC
    J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up by coronary angiography in a patient with heterozygous familial hypercholesterolemia: a case report.
    Saku K; Takeda Y; Shirai K; Nii T; Ohta T; Arakawa K
    J Cardiol; 1997 Sep; 30(3):137-42. PubMed ID: 9309510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
    Park JW; Merz M; Braun P
    Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One year experience with a low density lipoprotein apheresis system.
    Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
    Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.